AspirinAsthmaPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalAnti-Asthmatic AgentsTiclopidineAsthma, Exercise-InducedThromboxane B2Cyclooxygenase InhibitorsPlatelet AggregationAdministration, InhalationPeak Expiratory Flow RateSalicylatesAsthma, Aspirin-InducedAsthma, OccupationalForced Expiratory VolumePlatelet Function TestsDrug Therapy, CombinationBronchial HyperreactivityBronchodilator AgentsRespiratory SoundsAllergensAdrenal Cortex HormonesHypersensitivityDouble-Blind MethodRisk FactorsRhinitisBlood PlateletsSodium SalicylateHypersensitivity, ImmediateFibrinolytic AgentsRespiratory Function TestsAlbuterolMethacholine ChlorideTreatment OutcomeHemorrhageDose-Response Relationship, DrugRhinitis, Allergic, PerennialAnticoagulantsWarfarinTablets, Enteric-CoatedCyclooxygenase 1Prospective StudiesEosinophilsSpirometryBronchiSeverity of Illness IndexProstaglandin-Endoperoxide SynthasesBudesonideBleeding TimePlatelet ActivationGastrointestinal HemorrhagePrevalenceThromboxanesTime FactorsBeclomethasoneQuestionnairesSkin TestsLeukotriene AntagonistsIbuprofenLungNebulizers and VaporizersThromboxane A2AcetaminophenThrombosisFollow-Up StudiesDrug ResistanceCyclooxygenase 2 InhibitorsAnti-Inflammatory AgentsLipoxinsStatus AsthmaticusBronchoconstrictor AgentsAirway RemodelingDipyridamoleCohort StudiesCase-Control StudiesBronchoconstrictionAdrenergic beta-AgonistsBronchitisDrug HypersensitivityIndomethacinRespiratory HypersensitivityOvalbuminMyocardial InfarctionPyroglyphidaeDrug Administration ScheduleSulfinpyrazoneCyclooxygenase 2Gastric MucosaOdds RatioStrokeProstaglandinsPrimary PreventionReye SyndromeIncidencePulmonary MedicineRandomized Controlled Trials as TopicGlucocorticoidsStomach UlcerVital Capacity